|
SEC23A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.751830E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.184500E-04 |
| Normal-vs-Stage2 |
8.706000E-01 |
| Normal-vs-Stage3 |
2.939000E-03 |
| Normal-vs-Stage4 |
1.182020E-02 |
| Stage1-vs-Stage2 |
3.270400E-02 |
| Stage1-vs-Stage3 |
9.893000E-01 |
| Stage1-vs-Stage4 |
8.535600E-01 |
| Stage2-vs-Stage3 |
4.402100E-02 |
| Stage2-vs-Stage4 |
5.226400E-02 |
| Stage3-vs-Stage4 |
8.713600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.63270000000027E-05 |
| Normal-vs-AfricanAmerican |
1.838050E-02 |
| Normal-vs-Asian |
2.511500E-02 |
| Caucasian-vs-AfricanAmerican |
4.469400E-01 |
| Caucasian-vs-Asian |
8.559600E-01 |
| AfricanAmerican-vs-Asian |
4.532400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.460430E-02 |
| Normal-vs-Female |
1.444110E-04 |
| Male-vs-Female |
4.961200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.73875999999185E-05 |
| Normal-vs-Age(41-60Yrs) |
1.194090E-02 |
| Normal-vs-Age(61-80Yrs) |
1.827040E-01 |
| Normal-vs-Age(81-100Yrs) |
1.923350E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.192400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.501630E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.226800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.770800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.800400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.542600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.100000E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
8.408300E-02 |
| Classical-VS-Normal |
3.25469999840067E-08 |
| Tall-VS-Follicular |
9.32640000006479E-07 |
| Tall-VS-Other |
5.125500E-02 |
| Tall-VS-Normal |
8.235200E-04 |
| Follicular-VS-Other |
3.449000E-01 |
| Follicular-VS-Normal |
4.824800E-03 |
| Other-VS-Normal |
7.411200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.629200E-01 |
| Normal-vs-N1 |
5.341500E-03 |
| N0-vs-N1 |
1.694150E-02 |
|
|
